Navigation Links
Researchers Spot Potential Bile Duct Cancer Drug Targets

THURSDAY, Jan. 26 (HealthDay News) -- Researchers who identified a new genetic signature associated with bile duct cancer say their discovery could lead to targeted treatment for the deadly cancer.

The team at the Massachusetts General Hospital Cancer Center screened samples from 287 patients with gastrointestinal tumors and found that growth-enhancing mutations in two genes (IDH1 and IDH2) may account for nearly one-fourth of bile duct tumors that develop in the liver.

Mutations in IDH1 were found in 13 percent of all bile duct tumors and in 23 percent of those within the liver itself. Mutations in IDH2 were less common.

It may be possible to develop drugs that target this mutation in order to control tumor growth, they said.

The findings were published online in The Oncologist.

Bile duct cancer occurs in a duct that carries bile from the liver to the small intestine.

"Patients with bile duct cancer have a generally poor prognosis. Most of them are diagnosed with advanced or metastatic disease, so surgical resection [removal] is not feasible," study co-senior author Dr. Andrew Zhu, director of Liver Cancer Research at the MGH Cancer Center, said in a hospital news release.

"Identifying this new and relatively common mutation in intrahepatic [within the liver] bile duct cancer may have significant implications for the diagnosis, prognosis and therapy of patients whose tumors harbor this mutation," Zhu added.

Currently, there are no drugs that target IDH mutations, but extensive efforts are underway to develop such drugs, the researchers say.

Each year in the United States, 12,000 people are diagnosed with cancers of the gallbladder and bile duct, but only 10 percent of those cancers are discovered early enough for successful surgical treatment. Average survival, even with chemotherapy, is less than a year.

More information

The American Cancer Society has more about bile duct cancer.

-- Robert Preidt

SOURCE: Massachusetts General Hospital, news release, Jan. 18, 2012

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Georgetown Lombardi researchers present new findings on head & neck cancers
2. Researchers discover method to unravel malarias genetic secrets
3. Researchers quantify muscle soreness
4. Georgetown professor applauds decision of researchers to temporarily halt research on H5N1
5. Health benefits of exercise may depend on cellular degradation, UT Southwestern researchers report
6. Autism redefined: Yale researchers study impact of proposed diagnostic criteria
7. University of Tennessee researchers develop comprehensive, accessible vision testing device
8. Lawson researchers engineer a switch to tame aggressive cancers
9. UC Davis researchers refine nanoparticles for more accurate delivery of cancer drugs
10. Researchers study how chemicals in drugs and around us impact stem cells
11. University of Granada researchers identify changes in tumor cells that lead to metastasis
Post Your Comments:
Related Image:
Researchers Spot Potential Bile Duct Cancer Drug Targets 
(Date:11/30/2015)... Minneapolis, MN (PRWEB) , ... November 30, 2015 ... ... launched at . The directory is specialized and only includes chiropractic ... is to find a competent and trustworthy alternative health practitioner when back pain ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... vehicle experience this summer, ushering in a new era of publicly accessible automated ... electric shuttle, will continue to offer guests an up-close look at the shuttle ...
(Date:11/30/2015)... ... 2015 , ... In an effort to provide local families ... Christian Church of Flint, MI, hosted a family-oriented evening themed on “Candy Land”, ... candy dubbed “Candy Mountain”. , A Forever Recovery, a holistic treatment center for ...
(Date:11/30/2015)... ... November 30, 2015 , ... In an effort to ... to access life-saving information provided directly from top experts in mesothelioma, in 2016 ... conferences in three major cities: Houston, San Francisco, and Chicago. , “For ...
(Date:11/30/2015)... VA (PRWEB) , ... November 30, 2015 , ... ... Foundation kicked off its annual fundraising campaign to raise funds for its research, ... raises approximately 10% of the organization’s annual funding. , The Mesothelioma Applied Research ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Die MEDTEC Japan 2016, ... Entwicklung und Herstellung medizinischer Geräte, findet ... in Tokyo ... Foto: ... --> ...
(Date:11/30/2015)... India , December 1, 2015 /PRNewswire/ ... --> adds "Endometriosis - Pipeline ... provides an overview on therapeutic pipeline of ... to create effective counter strategies to gain ... identifying new targets and MOAs to produce ...
(Date:11/30/2015)... Nevro Corp. (NYSE: NVRO ), a global ... the treatment of chronic pain, today announced that the Patent ... Trademark Office (USPTO) has denied instituting an inter partes ... patent).  --> --> ... filed two petitions challenging the validity of certain claims of ...
Breaking Medicine Technology: